Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
March 1, 1992
Involvement of the adrenal glands in the prolactin rise induced in the female rat by an antiprogestin, onapristone
Y Nishino, H Michna, S H Hasan, et al.
Archives of Toxicology
|
February 24, 2001
Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments
H M Bolt, P Janning, H Michna, et al.
International Journal of Sports Medicine
|
November 18, 2006
Exercise associated genes in rat colon mucosa: upregulation of ornithin decarboxylase-1
K Buehlmeyer, F Doering, H Daniel, et al.
Breast Cancer Research and Treatment
|
December 8, 2000
Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells
K Smolnikar, S Löffek, T Schulz, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft
|
September 5, 1998
Functional activity of immune cells in female MS-patients
C Peters, H Lötzerich, A Raabe-Oekter, et al.
Journal of Steroid Biochemistry
|
January 1, 1989
The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death
H Michna, M R Schneider, Y Nishino, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
Progesterone receptor repression by estrogens in rat uterine epithelial cells
K Parczyk, R Madjno, H Michna, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 1, 1992
The antitumor potency of progesterone antagonists is due to their differentiation potential
H Michna, S Gehring, W Kühnel, et al.
Breast Cancer Research and Treatment
|
December 1, 1989
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies
H Michna, M R Schneider, Y Nishino, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models
M R Schneider, H Michna, Y Nishino, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
The Journal of Steroid Biochemistry and Molecular Biology
|
March 1, 1992
Involvement of the adrenal glands in the prolactin rise induced in the female rat by an antiprogestin, onapristone
Y Nishino, H Michna, S H Hasan, et al.
Archives of Toxicology
|
February 24, 2001
Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments
H M Bolt, P Janning, H Michna, et al.
International Journal of Sports Medicine
|
November 18, 2006
Exercise associated genes in rat colon mucosa: upregulation of ornithin decarboxylase-1
K Buehlmeyer, F Doering, H Daniel, et al.
Breast Cancer Research and Treatment
|
December 8, 2000
Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells
K Smolnikar, S Löffek, T Schulz, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft
|
September 5, 1998
Functional activity of immune cells in female MS-patients
C Peters, H Lötzerich, A Raabe-Oekter, et al.
Journal of Steroid Biochemistry
|
January 1, 1989
The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death
H Michna, M R Schneider, Y Nishino, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
Progesterone receptor repression by estrogens in rat uterine epithelial cells
K Parczyk, R Madjno, H Michna, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 1, 1992
The antitumor potency of progesterone antagonists is due to their differentiation potential
H Michna, S Gehring, W Kühnel, et al.
Breast Cancer Research and Treatment
|
December 1, 1989
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies
H Michna, M R Schneider, Y Nishino, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models
M R Schneider, H Michna, Y Nishino, et al.
Page
of 7